Article PDF
Avoid common mistakes on your manuscript.
References
Chen J, Chen J, Wang L, 2022. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor infiltrating immunocytes. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10): 812–822. https://doi.org/10.1631/jzus.B2200174
Fang L, Qi H, Wang P, et al., 2022. UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):863–875. https://doi.org/10.1631/jzus.B2200144
Gao ZR, Ling XY, Shi CY, et al., 2022. Tumor immune checkpoints and their associated inhibitors. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):823–843. https://doi.org/10.1631/jzus.B2200195
Gu TN, Zhu M, Huang H, et al., 2022. Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):793–811. https://doi.org/10.1631/jzus.B2200256
Kong DL, Yang TT, Geng J, et al., 2022. Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):876–880. https://doi.org/10.1631/jzus.B2200128
Qu L, He XY, Tang Q, et al., 2022. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):844–862. https://doi.org/10.1631/jzus.B2200194
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, A. Cancer immunotherapy: an evolving paradigm. J. Zhejiang Univ. Sci. B 23, 791–792 (2022). https://doi.org/10.1631/jzus.B2210001
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B2210001